Google Alert - "LSD1 inhibitor" OR "sickle cell disease" · Scour

What Agios Pharmaceuticals (AGIO)'s FDA-Backed Accelerated Path for Mitapivat in Sickle ...

Rewriting the Hemoglobin Switch: CRISPR Targeting in Sickle Cell Disease

Vertex Pharmaceuticals Inc stock: New Halozyme deal signals pipeline push

Beam to seek OK of gene-edited cell therapy risto-cel for sickle cell disease

Georgia lawmakers pass Sickle Cell Disease Protection Act, expanding care for thousands statewide

Sickle cell disease heightens risk for precancerous blood disorder

EEOC sues international shipping company on behalf of Atlanta employee

Red Cross of Wyoming to host blood drives in Cheyenne

CRISPR Therapeutics to Present at Annual Healthcare Conference

Rewriting Life Before Birth: Entering the Fetal Genetic Intervention Era

The lifesaving power of stem cell donation starts with awareness

ChristianaCare Gene Editing Institute receives $500K federal grant to expand student ...

KNUST to host national World Sickle Cell Awareness Day event

Deadly diseases in Minnesota newborns to be targeted in new whole-genome study

Yan Leyfman: Gene Editing Rapidly Redefines What is Possible in Sickle Cell Disease

Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position?

Newborn DNA screening: What's changing in the UK and where private testing fits

Beyond Pertussis: Bordetella holmesii Bacteremia in Children With Sickle Cell Disease

Blood centre at SSG Hospital hits historic highs | Vadodara News

Milanova, Agios Pharmaceuticals CCO, sells $113k in stock

Log in to enable infinite scrolling